PortfoliosLab logoPortfoliosLab logo
IXJ vs. SBIO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IXJ vs. SBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Global Healthcare ETF (IXJ) and ALPS Medical Breakthroughs ETF (SBIO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IXJ achieves a -5.26% return, which is significantly lower than SBIO's -0.39% return. Both investments have delivered pretty close results over the past 10 years, with IXJ having a 7.66% annualized return and SBIO not far ahead at 8.02%.


IXJ

1D
0.39%
1M
0.34%
YTD
-5.26%
6M
-4.88%
1Y
9.30%
3Y*
4.42%
5Y*
4.02%
10Y*
7.66%

SBIO

1D
1.41%
1M
-7.56%
YTD
-0.39%
6M
3.05%
1Y
65.41%
3Y*
17.80%
5Y*
2.68%
10Y*
8.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IXJ vs. SBIO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IXJ
iShares Global Healthcare ETF
-5.26%14.99%0.55%3.62%-4.94%19.60%12.74%23.23%2.83%20.44%
SBIO
ALPS Medical Breakthroughs ETF
-0.39%55.07%3.81%8.68%-28.08%-17.55%21.17%50.30%-11.81%45.67%

Correlation

The correlation between IXJ and SBIO is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.50

Correlation (3Y)
Calculated over the trailing 3-year period

0.48

Correlation (5Y)
Calculated over the trailing 5-year period

0.50

Correlation (10Y)
Calculated over the trailing 10-year period

0.55

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2015

0.57

The correlation between IXJ and SBIO has been stable across timeframes, ranging from 0.48 to 0.57 - a consistent structural relationship.

IXJ vs. SBIO - Sectors Allocation Comparison


Sectors
IXJ
SBIO

Healthcare

98.9%
100.0%

Consumer Defensive

0.5%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Energy

-

-

Financial Services

-

-0.0%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IXJ
98.9%
SBIO
100.0%

Consumer Defensive

IXJ
0.5%
SBIO

-

Basic Materials

IXJ

-

SBIO

-

Communication Services

IXJ

-

SBIO

-

Consumer Cyclical

IXJ

-

SBIO

-

Energy

IXJ

-

SBIO

-

Financial Services

IXJ

-

SBIO
-0.0%

Industrials

IXJ

-

SBIO

-

Real Estate

IXJ

-

SBIO

-

Technology

IXJ

-

SBIO

-

Utilities

IXJ

-

SBIO

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IXJ vs. SBIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IXJ
IXJ Risk / Return Rank: 1919
Overall Rank
IXJ Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
IXJ Sortino Ratio Rank: 2020
Sortino Ratio Rank
IXJ Omega Ratio Rank: 1818
Omega Ratio Rank
IXJ Calmar Ratio Rank: 2020
Calmar Ratio Rank
IXJ Martin Ratio Rank: 1919
Martin Ratio Rank

SBIO
SBIO Risk / Return Rank: 7272
Overall Rank
SBIO Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
SBIO Sortino Ratio Rank: 6767
Sortino Ratio Rank
SBIO Omega Ratio Rank: 5959
Omega Ratio Rank
SBIO Calmar Ratio Rank: 8888
Calmar Ratio Rank
SBIO Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IXJ vs. SBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IXJSBIODifference

Sharpe ratio

Return per unit of total volatility

0.64

2.24

-1.60

Sortino ratio

Return per unit of downside risk

1.06

3.10

-2.04

Omega ratio

Gain probability vs. loss probability

1.12

1.36

-0.24

Calmar ratio

Return relative to maximum drawdown

0.87

5.19

-4.33

Martin ratio

Return relative to average drawdown

2.11

15.57

-13.45

IXJ vs. SBIO - Sharpe Ratio Comparison

The current IXJ Sharpe Ratio is 0.64, which is lower than the SBIO Sharpe Ratio of 2.24. The chart below compares the historical Sharpe Ratios of IXJ and SBIO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IXJSBIODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.64

2.24

-1.60

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.28

0.08

+0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.49

0.24

+0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

0.42

0.21

+0.20

Drawdowns

IXJ vs. SBIO - Drawdown Comparison

The maximum IXJ drawdown since its inception was -40.60%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for IXJ and SBIO.


Loading charts...

Drawdown Indicators


IXJSBIODifference

Max Drawdown

Largest peak-to-trough decline

-40.60%

-63.06%

+22.46%

Max Drawdown (1Y)

Largest decline over 1 year

-10.78%

-12.66%

+1.88%

Max Drawdown (3Y)

Largest decline over 3 years

-18.14%

-42.44%

+24.30%

Max Drawdown (5Y)

Largest decline over 5 years

-18.14%

-53.10%

+34.96%

Max Drawdown (10Y)

Largest decline over 10 years

-27.35%

-63.06%

+35.71%

Current Drawdown

Current decline from peak

-9.27%

-16.79%

+7.52%

Average Drawdown

Average peak-to-trough decline

-6.92%

-28.45%

+21.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.41%

4.22%

+0.19%

Volatility

IXJ vs. SBIO - Volatility Comparison

The current volatility for iShares Global Healthcare ETF (IXJ) is 3.75%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.48%. This indicates that IXJ experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IXJSBIODifference

Volatility (1M)

Calculated over the trailing 1-month period

3.75%

9.48%

-5.73%

Volatility (6M)

Calculated over the trailing 6-month period

10.05%

22.70%

-12.65%

Volatility (1Y)

Calculated over the trailing 1-year period

14.55%

29.42%

-14.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.21%

33.56%

-19.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.67%

33.17%

-17.50%

IXJ vs. SBIO - Expense Ratio Comparison

IXJ has a 0.46% expense ratio, which is lower than SBIO's 0.50% expense ratio.


Dividends

IXJ vs. SBIO - Dividend Comparison

IXJ's dividend yield for the trailing twelve months is around 1.47%, while SBIO has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
IXJ
iShares Global Healthcare ETF
1.47%1.40%1.50%1.38%1.17%1.12%1.27%1.42%2.11%1.46%1.73%2.85%
SBIO
ALPS Medical Breakthroughs ETF
0.00%0.00%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%0.00%0.00%

Frequently Asked Questions


IXJ and SBIO have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SBIO has higher volatility (9.48%) compared to IXJ (3.75%). In terms of maximum drawdown, IXJ dropped -40.60% vs SBIO's -63.06%.

On 10-year performance, SBIO leads with 8.02% vs 7.66% for IXJ. On fees, IXJ is cheaper at 0.46% per year. On volatility, IXJ has been the lower-risk option at 3.75%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SBIO has performed better with a 8.02% return vs 7.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IXJ is cheaper with a 0.46% expense ratio, compared with 0.50% for SBIO.

IXJ has the higher dividend yield at 1.47%, compared with 0.00% for SBIO.

IXJ tracks S&P Global Healthcare Sector Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: iShares and SS&C. Their fees differ too: 0.46% for IXJ and 0.50% for SBIO.

SBIO currently has the higher Sharpe Ratio (2.24 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IXJ and SBIO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer